Anti-Cancer Drugs Publishes Preclinical Data Demonstrating :

Misetionamide showed broad antineoplastic activity in 15 different cancer types including multiple human cancer cell lines with no detrimental effect on...

Related Keywords

Switzerland , Swiss , Greg Bosch , Sara Krane , Lisa Descenza , Linkedin , Panavance Therapeutics Inc , Head Nonclinical Research , Anti Cancer Drugs , Duane Sofia , Cancer Drugs , Investor Relations Contact , Preclinical Data , Ntineoplastic Activity , R Duane Sofia , Cancer Cell ,